Skip to content

Distribution of Highly Sensitive Troponin in the Critically Unwell & Associated Mortality

Distribution of Highly Sensitive Troponin in the Critically Unwell & Associated Mortality. The DIGNITY Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03630237
Acronym
DIGNITY
Enrollment
1500
Registered
2018-08-14
Start date
2019-01-28
Completion date
2019-10-01
Last updated
2019-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial Infarction, Myocardial Injury

Brief summary

The current diagnostic criteria for a heart attack require evaluation of a patient's symptoms and ECG but importantly a blood test called troponin. With advancing technology this test has become more sensitive and is now called a high sensitivity troponin. This is a very effective way of rapidly excluding a heart attack if the test is negative. However there are a number of causes of a raised high sensitivity other than a heart attack, particularly critical illness states. In the absence of features of a heart attack an abnormal result therefore suggests that the heart is inflamed or unwell causing the release of high sensitivity troponin. The DIGNITY study will examine the consequences of high sensitivity troponin elevation in patients in intensive care and assess whether it has a role as a biomarker for predicting outcome.

Interventions

None listed

Sponsors

University Hospital Southampton NHS Foundation Trust
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients (aged 18 years or older) admitted to any of the three intensive care facilities on site (general, cardiac and neurosciences) * Biochemistry samples already taken as part of routine clinical care during the ICU stay

Exclusion criteria

* Patients aged less than 18 years * No biochemistry samples taken within the ICU stay

Design outcomes

Primary

MeasureTime frame
Association between high sensitivity troponin and inpatient mortality on all patients admitted to each of the ICU environments at a large teaching hospitalDuring intensive care admission

Secondary

MeasureTime frameDescription
Distribution of high sensitivity troponin results for different admissions to intensive careDuring intensive care admissionDistribution of high sensitivity troponin results in * Medical admissions * Trauma / emergency surgical admissions * Planned surgical admissions * Post cardiac surgical patients * Neurosurgical patients
Association between high sensitivity troponin results and duration of ventilationWithin twenty eight days
Association between high sensitivity troponin results and length of intensive care admissionNumber of days not in intensive care within twenty eight days of original intensive care admission
Association between high sensitivity troponin results and requirement for inotropic supportDuring intensive care admission

Countries

United Kingdom

Contacts

Primary ContactJonathan Hinton
jonathan.hinton@uhs.nhs.uk0044 (0)2380777222
Backup ContactZoe Nicholas
zoe.nicholas@uhs.nhs.uk0044 (0)2380777222

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026